TTR and axial length measurement: Over the past decade, cardiac amyloidosis has shifted from an uncommon and often overlooked diagnosis to a condition increasingly identified across diverse cardiovascular populations, driven by the growing understanding that transthyretin amyloidosis is far more prevalent—especially among older adults—and that both AL and ATTR forms frequently mimic more common cardiac diseases.